It has been known for over 30 years that olfactory brain via the nasal route, but the reason for olfactory dysfunction may be more subtle. Evidence for olfactfunction is disordered in idiopathic Parkinson's disease (IPD). The severity and partial specificity of ory disturbance is reviewed from pathological, psychological, neurophysiological and genetic standanosmia was not realized until recently, with the advent of more detailed analysis and sophisticated points. It is proposed that the initial causative event in IPD may start in the rhinencephalon (olfactory measurement. The olfactory vector hypothesis suggests that the causative agent for IPD enters the brain) prior to damage in the basal ganglia.
Introduction
It is well established that many neurodegenerative one brain showed Alzheimer-type change in the diseases are associated with impaired sense of smell, amygdala, adjacent anterior temporal cortex and CA2 including Alzheimer's disease, Huntington's chorea, sector of the hippocampus. The hippocampus was and multiple system atrophy ( Table 1 ). The majority of normal in the remaining three. It is uncertain whether patients with idiopathic Parkinson's disease (IPD) have all central olfactory areas were examined; furtherdefective smell sense, although this is still not widely more the cases were complicated by the presence appreciated. To make plausible a theory that the of dementia. More recently, we examined 'blind' to condition is primarily olfactory, there needs to be clinical information, the olfactory bulbs and tracts evidence that the olfactory system is consistently and from formalin-fixed brains of eight controls and eight severely involved to a degree equalling or exceeding patients with a clinical and pathological diagnosis that of the classical motor triad of tremor, rigidity and of IPD taken from the UK Parkinson's Disease Brain akinesia. Furthermore, a mechanism of secondary Bank.2 By inspecting the olfactory bulb and tract, all motor involvement needs to be demonstrated. eight cases were correctly diagnosed 'probable PD'. Evidence in support is presented in this article.
Lewy bodies were most numerous in the anterior olfactory nucleus, but they were also found in mitral cells. Cortical Lewy bodies, mainly in the anterior cingulate gyrus and parahippocampus, were also Pathological evidence plentiful in two patients. It was subsequently shown that the loss of anterior olfactory neurons correlated The basal ganglia have been intensively studied with disease duration.3 The pathological evidence in PD, but the rhinencephalon has not been investiconfirms the presence of cellular damage charactergated systematically. In an examination of four Parkinson's disease (PD) patients with dementia,1 istic of PD in the olfactory bulb and hippocampus. The relative degree of central versus peripheral involvement has not yet been determined pathologically, nor has it been shown whether there are Lewy bodies in the neurons of the nasal olfactory epithelium.
Smell identification evidence
The first large-scale olfactory study was by Doty and colleagues4 using the University of Pennsylvania Smell Identification Test (UPSIT).5 This uses microencapsulated odorants that are released on scratching the strip with a pencil. There are 40 different odors, and a forced choice is made from four possible also demonstrated that the deficit was of the same magnitude in both nostrils, and was uninfluenced by anti-Parkinsonian medication. In their largest study8 selective odor deficit.12 Odors most readily misidentified by PD patients on the UPSIT test were lemon, based on 180 IPD patients, they defined cut-off scores for discriminating controls from PD patients, pizza, wintergreen, rose and clove. Pizza was the best single discriminant odor, with pizza and wintere.g. a male of 60 years who scored 31 or less might be suspected of having the disease. green in combination superior still. Thus a subject could be suspected of having PD if both pizza and We undertook a comparable survey9,10 using UPSIT on healthy members of Hospital and British wintergreen were inaccurately identified and would probably not have the disease if both of these odors Telecom staff. All patients had IPD, although the fallibility of such classification is about 16%.11 There were positively smelt correctly (i.e. not by random guessing). Because patients made a forced choice were 155 PD cognitively intact, non-depressed patients aged 34-84 years, and 156 controls aged from four possibilities, 25% will be correct by chance alone. Hence our sensitivity value of 76% for pizza 17-90 years. The UPSIT scores for PD patients were significantly lower than controls. Only 19% (30/155) in the presence of 90% specificity infers anosmia to 'UPSIT-pizza' odor for PD patients. Pizza is a comof the PD patients had a score within the level expected for 95% of our age-matched healthy conplex odor, with oregano as the most distinguishing characteristic. In turn oregano is a highly complex trols ( Figure 1 ). There were 65 (42%) who were anosmic, i.e. scoring <17. There was no correlation mix of several organic chemicals.
It is intriguing that all six patients with MPTP between disease duration and UPSIT score (r= 0.074), in keeping with earlier work.4 While there is parkinsonism had normal smell sense13 when evaluated by UPSIT and olfactory threshold tests. If the a background depression of olfactory identification, superimposed upon this we found a degree of olfactory vector hypothesis is correct (q.v.) then damage to the olfactory system by intravenous toxins degeneration etc.17 and, if so, abnormality on olfactory tests may be even more specific. might not be expected. Furthermore MPTP-induced parkinsonism is significantly different from IPD on clinical and pathological grounds.
Genetic evidence
Although it awaits confirmation, our UPSIT study
Neurophysiological evidence
infers there may be an inherited specific anosmia to some of the chemicals that give pizza (oregano?) We tested 73 patients with IPD by olfactory evoked potential (OEP) recording.9,10 In 36 (49%), responses and perhaps wintergreen their distinguishing characteristics. Anosmia to perhaps one component of these were either absent or unsatisfactory for technical reasons. Regression analysis on the 37 with a measurodors might remove an individual's ability to identify it. Our observations on selective odor defects in able trace showed that for hydrogen sulphide (H 2 S) a highly significant latency difference existed UPSIT raise the possibility of congenital or acquired selective hyposmia in PD-comparable to androsbetween diagnostic groups (i.e. control or PD). Assuming that the 36/73 who had no detectable OEP tenone smell blindness, which affects 20%-47% of healthy individuals.18 Of particular relevance is an were abnormal and combining this with the abnormal 12/37 (32%), 81% had an abnormality on OEP, experiment in which rats were exposed to 44 inhaled vapours for several weeks.19 For each odor, there which is the same as for UPSIT measurements. In 10 patients with normal UPSIT scores, there was one was a selective pattern of mitral cell loss in the olfactory bulb, unrelated to odor concentration. It is with absent H 2 S responses and three with significantly prolonged latency to H 2 S. Responses were not conceivable that olfactory damage in PD may be caused by exposure to a neurotoxic vapour, which obtained in about half the patients tested, but this is not surprising since they had a poor sense of smell selectively injures part of the olfactory system. Speculatively, one could 'work back' from the olfactgenerally and the small number of delayed H 2 S responses in those we could test may be a reflection ory bulb pathology and describe the chemical characteristics of a possible neurotoxin. Alternatively if of a healthier population in the olfactory sense. A record labelled absent may in fact contain a response there is indeed a congenital inability to smell certain odors, they might be inhaled inadvertently and below the limit of detection imposed by averaging, in our case, just 16 signals. We used only one odour, repeatedly. If the specific anosmia relates to a neurotoxin such as pyridine, then damage to distal whereas the UPSIT implements 40. If a large number of different gases were used, the sensitivity of OEP and thereafter central parts of the olfactory pathway might result. might well increase.
Similar results were subsequently obtained14 in 31 In the majority of patients, IPD is a sporadic condition. Estimates from large community-based patients with PD tested by OEP to vanillin and H 2 S. Responses were obtained to both stimulants in all case-control studies suggest that just over 1% firstdegree relatives will have the same condition.20 patients. Prolonged latencies were seen in the PD patients, whether they were taking medication for There are clear instances of autosomal dominant PD with large pedigrees and pathological confirmation.21 the disease or not. More marked changes were seen in those on treatment, however. The same group15
Recent evidence22 from Italian and Greek kindreds has demonstrated a point mutation of the gene demonstrated for the first time a correlation between disability (as measured by Webster score) and latency coding for a-synuclein. Rat synucleins show considerable homology with the human counterpart. By in to H 2 S OEP. Viewed alone the UPSIT result places 81% of situ hybridization23 it was shown that the three varieties of synuclein mRNA were expressed in patients outside the 95% limit for controls. When this information is combined with OEP data (4/10 discrete areas. Strongest expression (++++) was in the lateral olfactory tract, hippocampus, dentate abnormal where UPSIT score was normal) the fraction of olfactory abnormality approaches 90%. Such gyrus, habenula and pyriform cortex. The olfactory bulb was graded (+++) and less expression was frequency is higher than that of tremor, which is usually quoted at 70%16 and nearly equals that of seen (++) in caudate-putamen, substantia nigra, dorsal raphe nuclei and granular layer of the cerebelrigidity and akinesia. At least for a hospital population, olfactory dysfunction is common and potentially lum. The areas of major expression of synuclein in human brain are not yet characterized, but the as important as the cardinal motor signs of PD. It is possible that patients with a normal UPSIT score had pattern in the rat at least, corresponds to primary olfactory areas, with the strianigral system very much a parkinsonian syndrome such as progressive supranuclear palsy, multiple system atrophy, corticobasal in second place.
that any progression is simply due to age-related
Mechanism of damage neuronal loss in SN.32 Why is a movement disorder such as PD so consistently associated with hyposmia? The olfactory identiDefective P450 cytochrome fication defect in PD is similar to AD;24 there is profound disturbance of cognition in AD, but much
In some PD patients, there is a mutation in the less in PD, and the olfactory tests in PD have all P450 cytochrome CYP2D6-debrisoquine hydroxylase been done in patients with normal cognitive function.
gene.33 Mammalian P450-dependent oxygenases One possibility is that a virus or chemical agent that provide a central line of defence against exogenous gains entry to the CNS via the nose causes PD.
toxins, and it has been shown that the risk of PD is Indeed this theory has been raised previously to higher in those with a P450 genetic polymorphism explain both Alzheimer's disease24-26 and (briefly) associated with deficient debrisoquine metabolism. for PD.27
Whilst the high concentration of P450 in hepatic microsomes is well known, it has also been shown that microsomes in the olfactory epithelium of, for Nasal entry of virus or chemical example, the rat34 and rabbit35 have high levels of P450. These are sometimes in excess of those in HSV1 virus placed intra-nasally in 6-week-old mice was detectable in the trigeminal root entry zone and the liver, depending on the particular subtype. The olfactory bulb of the monkey has particularly olfactory bulbs 4 days later.28 In some mice, virus which had entered the olfactory bulb spread as far high P450 levels compared to other parts of its brain.
There are variable levels of P450 in the rest of as temporal lobe, hippocampus and cingulate cortex. Horseradish peroxidase (HRP) applied intranasally the CNS, but most areas are incompletely characterized. Numerous volatile compounds are readily can be transported to the bulb, anterior olfactory nuclei and to transmitter-specific projection neurones absorbed by the nasal mucosa.36 Many non-volatile materials such as environmental pollutants can reach from the diagonal band (cholinergic), raphe (serotonergic), and locus coeruleus (noradrenergic). 29 the nasal mucosa, probably by adsorption on to small particles in the air that deposit on the nasal Because a large macromolecule such as HRP can spread so easily, it may be argued that environmental epithelium.37 Compounds absorbed by the nasal mucosa are actively metabolized in situ, sometimes contaminants and perhaps drugs of abuse could gain relatively unimpeded access to the entire nervous detoxified, or they may be activated to become more toxic or carcinogenic.38,39 Compounds that have system. It is not widely appreciated that there are significant and direct connections between primary been shown to be metabolized in vitro by the nasal P450-dependent monooxygenase system include olfactory areas and substantia nigra (SN). Application of horseradish peroxidase into the olfactory tubercle nasal decongestants, essences, anaesthetics, alcohols, nicotine, cocaine and many nasal carcinogens.40 results in anterograde labelling of the ipsilateral ventral tegmental area (VTA), SN pars reticulata as Herbicides such as dioxins41 or chlorthiamid,42 whether administered intravenously or intraperitonewell as the ventral pallidum and anterior olfactory nucleus.30 There was as expected, retrograde labelally, are selectively taken up by, and harmful to, the olfactory epithelium. The CNS distribution of ling in the ipsilateral olfactory bulb, anterior olfactory nucleus and other primary olfactory areas. Because CYP2D6 is not known, but if it were to be concentrated in the basal ganglia and olfactory pathways, the ventral striatum (VS), i.e. olfactory tubercle and nucleus accumbens, receives many projections from the pathology at these sites might be explained. Other cytochrome systems may be defective in PD, the limbic system, it is suggested that VS is concerned with integrating limbic information into the striatal while it is possible of course that the external agent, if there is one, gains entry to the brain via the system.
A further possibility relates to the fact that inhaled blood route. solvents such as trichloroethylene may rekindle activity in latent viruses such as herpes simplex.31 Support
Phylogeny of olfaction
for the nasal-entry theory might be strengthened if there was a correlation between the olfactory and Another explanation can be built upon the phylogeny of the olfactory system. In the reptile, the entire motor deficits-either in terms of symptom severity or duration. This has not been found clinically,4 but pallial field is olfactory. In the tortoise, there is a small area of non-olfactory differentiated cortex, there is probably a correlation between neuronal loss in the olfactory bulb and disease duration.3 At which is still under olfactory control. In the opossum, the hippocampus and pyriform cortex is well present, the possibility that individuals with anosmia later develop PD awaits proof. One could argue developed, and still more extensive than the nonolfactory cortex (neopallium), while in the human that PD is caused by a single major CNS insult and the neopallium is massive and crowds out the with late-onset disease, genetic factors appear less important, and if so an olfactory neurotoxin would olfactory cortex. A structure such as the hippocampus that is concerned with olfaction in lower species is remain a possible pathogenic mechanism. well developed in humans, but only part of its function is olfactory. It is possible that a highly conserved gene might have a multiple role in olfacConclusions tion, movement and cognition. It has been suggested recently that cells expressing netrin (an axon guidThere is much to suggest that a chemical toxin may cause PD. PD induced by drugs (e.g. phenothiazines) ance molecule) or dcc (the deleted in colorectal cancer gene) may control cell migration in the may be clinically indistinguishable from IPD and may last several months even after removal from developing cerebellum, optic nerve and olfactory epithelium and the establishment of connections exposure. Methyl-phenyl-tetrahydropyridine causes a severe and persisting form of PD in man and animals, to SN and corpus callosum. 43 As mentioned above, a mutation in the alpha synuclein gene is responsible and has structural similarity to the herbicide paraquat. There are isolated reports of parkinsonism for one form of autosomal dominant PD, and expression is strong in rat primary olfactory areas, much following exposure to this46 although it is doubted whether inhaled or ingested paraquat can enter the more so than the caudate-putamen and substantia nigra. This gives evidence at genetic level of a link brain in sufficient quantity to cause damage. 47 Nonetheless, many retrospective case control studies between the olfactory and extrapyramidal systems.
Phylogenetically, olfaction, movement and autosuggest increased risk of PD if there is history of exposure to pesticides.48 If PD is shown to relate to nomic control appear to be linked, and it is thus plausible that all would fail together in PD because environmental exposure, then the significance of contact with agrochemicals assumes great imporof a common defect in a highly conserved gene.
tance in view of the ability of many such compounds to damage the sense of smell.36-42 Given that the olfactory system in IPD is devast-
Disease specificity of hyposmia
ated, what evidence suggests that this is not of relevance, i.e. that the smell loss is an epiphenomParkinson's disease is not the only neurodegenerative condition associated with olfactory disorder.
enon of no etiological importance? (i) Clinical. About 20% of those with a clinical diagnosis of IPD have Hyposmia of similar degree is found clinically and pathologically in Alzheimer's disease.24 It should be normal smell identification. If hyposmia were a prerequisite for the diagnosis, the argument is weak. emphasized that all patients with PD tested by us9,10 and others4 had, by design, no evidence of cognitive
Conversely not all those with a clinical diagnosis of IPD have rigidity, some have no tremor, and impairment. Varying degrees of hyposmia occur in allied conditions as shown in Table 1 . It is of interest others have no akinesia. It is suggested that tremor is present in 70%, with rigidity or akinesia in 90%.16 that patients with benign essential tremor (reference 44 and own observations) have intact sense of
As mentioned above, we tested by OEP, 10 patients with a diagnosis of IPD who had normal UPSIT smell. Conversely, one might wish to review a diagnosis of IPD in someone with a normal UPSIT scores and of these, four had absent or delayed OEP, which implies that UPSIT does not test (nor would score. Hyposmia is thus not specific, merely characteristic of IPD. By the same token tremor, rigidity it be claimed to test) all aspects of the olfactory pathway. Pathological studies suggest that the diaand akinesia are all non-specific findings in PD, but we prefer to define the disease by its motor rather gnostic error rate for IPD is 16% or more11 and as mentioned already, olfactory identification is abnorthan sensory features.
Debate continues whether the aetiology of PD is mal in some parkinsonian syndromes (Table 1) . It is not yet known whether those with normal UPSIT genetic, environmental, or genetic susceptibility to an environmental agent. A large study of 193 male score are the very patients who have an incorrect diagnosis. Patients with MPTP-induced PD13 have twin pairs45 has shed new light on this area. In brief, the overall concordance ratio of monozygous to normal smell sense. In some ways this would be expected, as the agent is given intravenously, and dizygous twins was similar, implying weak genetic factors. Subgroup analysis of 16 pairs in whom onset there are significant differences in the clinical and pathological features of this disease from the spontanwas under 50 years showed 100% concordance rate in monozygous twins. In the remaining 12 dizygous eous variety. There are no studies of olfactory function in phenothiazine-induced PD but one would pairs, there were just two concordant pairs, giving a high heritability index of 0.94. This suggests that predict a normal result.
(ii) Smell identification and OEP. While there is agreement about the severity of genetic factors are strong in those with young age of onset. The twin study implies that for the majority olfactory loss in IPD, there was thought to be no correlation of such deficit with the duration, severity far was normal.52 This implies that the peripheral part of the olfactory system is relatively intact and or type of disease.4 Initial studies implied no correlation between severity of disease and olfaction, but it complements the pathological data. In IPD, smell identification and OEP are abnormal. has now been suggested that there is a correlation between disability (Webster score) and olfactory A final point to consider is what we mean by a disease. The frequency of the three cardinal signs evoked response latency.14 There seems to be no progression of smell identification with time4 and of PD is not well established, and was addressed only by Hoehn and Yahr16 at a time when parkinsonthere is only anecdotal evidence that impaired smell sense precedes the illness. At pathological level, ian syndromes were less well appreciated. No single sign is pathognomic of PD. Akinesia is most consisthowever, it has been shown3 that the number of neurons in AON decreases significantly with time.
ent, but it is absent, for instance, in benign tremulous PD and on its own is not diagnostic. The There may be a pathological change therefore which is not necessarily reflected in the clinical tests, or
absence of a precise clinical definition might be a reflection of our inadequate understanding of IPD. the tests may not be sufficiently sensitive. The incomplete clinical correlation weakens the primary Defective smell sense is found in about 80% of IPD classified clinically. What if there were patients with olfactory theory unless it is proposed that IPD is primarily a genetic process, e.g. there might be an tremor, rigidity and akinesia, of whom 80% were blind? Would this be classified as movement or inherited neuronal defect that causes delayed onset of damage in the olfactory and motor systems. The visual disorder? If the blindness came first the disease would probably be classified as a visual disorder olfactory defect might be the first to develop, and be ignored by patients (and clinicians). The disease and it would then be proposed that the condition was a visual problem with motor accompaniments. would then come to light only when the extrapyramidal features emerged. (iii) Pathological. While If blindness is replaced by anosmia, the analogy is complete. The most disabling symptoms and signs we found Lewy bodies in every olfactory bulb from pathologically confirmed IPD cases, this may not be (and indeed the initial symptoms and signs) do not necessarily equate with the primary causative relevant aetiologically. Lewy bodies are widespread in the brain and even the enteric nervous system. 49 mechanism. In summary, evidence at clinical level shows The Lewy body is nonetheless considered to be the hallmark of IPD. On clinical and pathological profound impairment of smell function both subjectively (UPSIT) and objectively (OEP) in about 80% of grounds it cannot be said whether involvement of the olfactory system in PD is disproportionate comhospital-based patients with IPD. There is unconfirmed insensitivity to pizza-like odor suggesting pared to the strianigral system, nor whether the disease starts in the olfactory system. The severity of specific anosmia, which could be congenital or acquired. Pathological evidence shows Lewy body Lewy body formation in olfactory compared to nonolfactory areas is unknown. Preliminary information change throughout the olfactory pathway. New genetic information implies that a-synuclein is primarily from a-synuclein expression in the rat suggests that the olfactory system is the site of major expression an olfactory pathway gene with significant but less marked expression in extrapyramidal sites. The evidof this gene. If the olfactory vector theory is correct then there should be more Lewy bodies in the ence of severe olfactory impairment in PD is overwhelming. It may be inferred therefore, that this is a peripheral parts of the olfactory system compared to more central rhinencephalic areas, but there are no primary phenomenon. Whether the damage starts in the olfactory pathways cannot be confirmed at precomparative data on this at present. We found most Lewy body damage in caudal (anterior olfactory sent, but we suggest that it does. nucleus) rather than rostral bulb structures,2 which is the reverse of what one would expect if the pathogen entered the CNS through the nose.
